193 related articles for article (PubMed ID: 33001159)
1. Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine: A Randomized Crossover Trial.
Kurian A; Reghunadhan I; Thilak P; Soman I; Nair U
JAMA Ophthalmol; 2020 Nov; 138(11):1160-1166. PubMed ID: 33001159
[TBL] [Abstract][Full Text] [Related]
2. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
4. A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension.
Mundorf TK; Ogawa T; Naka H; Novack GD; Crockett RS;
Clin Ther; 2004 Apr; 26(4):541-51. PubMed ID: 15189751
[TBL] [Abstract][Full Text] [Related]
5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
6. Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.
Cossack M; Nabrinsky E; Turner H; Abraham A; Gratton S
JAMA Neurol; 2018 Aug; 75(8):1024-1025. PubMed ID: 29799915
[TBL] [Abstract][Full Text] [Related]
7. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.
Aggarwal D; Heim AJ; Bittel B; Ford D; Dubinsky R; Gronseth G; Hairston V; Landazuri P; Sachen F; Herbelin L; Barohn RJ
Kans J Med; 2020; 13(Suppl 2):2-5. PubMed ID: 32256967
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.
Shedden A; Laurence J; Tipping R;
Clin Ther; 2001 Mar; 23(3):440-50. PubMed ID: 11318078
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
Bartlett JD; Boan K; Corliss D; Gaddie IB
J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
[TBL] [Abstract][Full Text] [Related]
12. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma.
Dickstein K; Hapnes R; Aarsland T
Am J Ophthalmol; 2001 Nov; 132(5):626-32. PubMed ID: 11704023
[TBL] [Abstract][Full Text] [Related]
13. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily.
Shedden AH; Laurence J; Barrish A; Olah TV
Doc Ophthalmol; 2001 Jul; 103(1):73-9. PubMed ID: 11678162
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.
Stewart WC; Day DG; Sharpe ED; Dubiner HB; Holmes KT; Stewart JA
Am J Ophthalmol; 1999 Dec; 128(6):692-6. PubMed ID: 10612504
[TBL] [Abstract][Full Text] [Related]
15. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
LeBlanc RP
Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
17. Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension.
Larsson LI
J Glaucoma; 2001 Apr; 10(2):109-14. PubMed ID: 11316092
[TBL] [Abstract][Full Text] [Related]
18. Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Suganami H; Araie M;
JAMA Ophthalmol; 2015 Jul; 133(7):755-61. PubMed ID: 25880207
[TBL] [Abstract][Full Text] [Related]
19. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
